SEC Form 4 · accession 0001518669-16-000004

Syneos Health, Inc. · SYNH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Apr 12, 2016

Accepted (ET)

Apr 14, 2016 · 8:26 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610950

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Apr 12, 2016	M	59,172	$10.57	A	138,398	D
Class A Common Stock	Apr 12, 2016	S	59,172	$48.00	D	79,226	D
Class A Common Stock	Apr 12, 2016	M	35,503	$10.57	A	114,729	D
Class A Common Stock	Apr 12, 2016	S	35,503	$48.00	D	79,226	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F2	$10.57	Apr 12, 2016	M	59,172	D	—	Jul 28, 2021	Class A Common Stock	59,172	120,035	D
Stock Option (Right to Buy Class A Common Stock)^F3	$10.57	Apr 12, 2016	M	35,503	D	—	Jan 1, 2023	Class A Common Stock	35,503	142,011	D

F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2015.
F2One half of the shares subject to this option vest yearly in five equal installments beginning on July 28, 2012, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
F3One half of the shares subject to this option vest yearly in five equal installments beginning on January 1, 2014, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.